Skip to content

Clinical trials

Stomach Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Country / region: Germany Clear all

155 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20022
20031
20042
20053
20064
20075
20084
20095
20106
201110
20127
20135
201410
20156
20169
20175
20188
20197
202013
20217
20227
20232
20246
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77
Terminated26
Recruiting20
Active, not recruiting15
Unknown status10
Not yet recruiting3
Withdrawn3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche10
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest8
AstraZeneca7
Krankenhaus Nordwest7
Amgen6
Eli Lilly and Company6
Bristol-Myers Squibb5
Charite University, Berlin, Germany5
European Organisation for Research and Treatment of Cancer - EORTC5
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms155
Esophageal Neoplasms30
Colorectal Neoplasms22
Pancreatic Neoplasms20
Ovarian Neoplasms13
Breast Neoplasms12
Neoplasm Metastasis12
Endometrial Neoplasms11
Carcinoma, Non-Small-Cell Lung10
Colonic Neoplasms10

Trials

Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.

55 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.